Remimazolam to improve outcomes after bladder tumor surgery
Treatments studied
Part of Brain & nervous system, Cancer, Kidney & urinary, Mental health, Women’s health & pregnancy clinical trials.
This trial tests whether the anesthesia medicine remimazolam can improve recovery and longer-term outcomes after surgery for early-stage bladder cancer. If you are having a bladder tumor procedure through the urethra, this study may help doctors understand whether this anesthesia choice matters for prognosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 50 and under 90 years old
- Have early bladder cancer that is non-muscle-invasive (Ta or T1)
- Be scheduled for bladder tumor removal using a scope through the urethra
- Be willing to join and sign written informed consent
- Not be having emergency surgery
- Not be using benzodiazepine medicines (anti-anxiety/sleep medicines) within the last month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This trial tests how a sedative drug called remimazolam affects working memory (the ability to hold and use information) in people with a type of brain tumor called glioma. It uses brain wave recordings to understand the drug's effect, which could help improve anesthesia care for brain surgery patients.
This study tests a medicine called remimazolam to see if it reduces confusion and agitation (emergence delirium) when children wake up from brain surgery. It may help your child have a smoother recovery.
This study compares two different anesthesia medicines (remimazolam and propofol) to see which helps people recover faster after surgery to remove tumors from the abdominal lining. It is for people with cancer that has spread to the peritoneal surface, and the surgery is expected to take at least 2 hours.
This trial tests a newer anesthetic drug, remimazolam, during heart surgery that uses a heart-lung machine. It aims to see if it is safe and works well for patients having this type of surgery.
This study tests a sedative called remimazolam to see how well it works and how safe it is for women having gynecologic surgery. It aims to find the best way to keep patients comfortable and stable during the procedure.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.